Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-08

FDA Approved: RAMIPRIL — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings' original application for ramipril (generic ramipril), enabling the company to market a ramipril product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

ORIG AP for RAMIPRIL (RAMIPRIL)